PGFC
BSX icon

Peapack-Gladstone Financial Corp’s Boston Scientific BSX Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,372
Closed -$321K – 654
2025
Q4 		$321K Sell
3,372
-1,828
-35% -$179K ﹤0.01% 568
2025
Q3 		$507K Buy
5,200
+2,277
+78% +$236K 0.01% 499
2025
Q2 		$314K Buy
2,923
+208
+8% +$21K ﹤0.01% 548
2025
Q1 		$274K Buy
2,715
+156
+6% +$15.7K ﹤0.01% 573
2024
Q4 		$229K Sell
2,559
-83
-3% -$7.31K ﹤0.01% 619
2024
Q3 		$221K Sell
2,642
-12
-0.5% -$946 ﹤0.01% 645
2024
Q2 		$204K Buy
+2,654
New +$194K ﹤0.01% 642

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Peapack-Gladstone Financial Corp's BSX Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,372 shares — an estimated $321K sold.

Peapack-Gladstone Financial Corp first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $507K in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Peapack-Gladstone Financial Corp reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 3,372 Boston Scientific shares in Q1 2026, an estimated $321K.
  • Peapack-Gladstone Financial Corp first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
  • Peapack-Gladstone Financial Corp's Boston Scientific position peaked at $507K in Q3 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.